Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee approves Risky Research Review Act to create presidential panel for high‑risk life‑sciences work
Summary
A Senate committee approved S.854, the Risky Research Review Act, to create a presidentially appointed panel to review high‑risk life‑sciences research and reduce conflicts of interest; supporters cited lab‑origin concerns and online availability of dangerous genetic material.
A Senate committee voted to advance S.854, the Risky Research Review Act, a measure to create a presidentially appointed panel to review high‑risk life‑sciences research and reduce conflicts of interest. The committee approved the bill by recorded voice/roll call and reported the motion agreed to after the tally showed more yeas than nays.
The measure’s sponsor told the committee the bill responds to concerns from U.S. intelligence agencies and the Department of Energy that COVID‑19 might have originated in a laboratory and to broader worries about risky research…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
